Trial Profile
A Retrospective Study Assessing the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism in Routine Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association
- 15 Mar 2018 New trial record
- 08 Mar 2018 Results published in the American Journal of Medicine.